Catalent Pharma Solutions

Rao Tatapudy, R. Ph., Ph.D. has been named vice president of Scientific Affairs, Innovation & Growth at Catalent Pharma Solutions. Dr. Tatapudy will be responsible for strategic programs in R&D and technology platforms with a focus on innovation and growth of current technology platforms and advances in bioavailability enhancement, taste masking, modified release and particle engineering. He will be located at Catalent’s corporate headquarters in Somerset, NJ.

Dr. Tatapudy joins Catalent from Pfizer, where he was New Product Leader and director of New Product and Process Development, with responsibility in Global Manufacturing services. Prior to Pfizer, he spent 21 years with Wyeth Pharmaceuticals in various departments including Brand, Toxicology, Generic, Life Cycle, Technical Operations and Product Supply (TO&PS) in various roles, including Project Management and Line Management. Prior to Wyeth he worked at Chelsea Labs (now Watson), Tata Pharma and GD Searle.

Kurt Nielsen, Catalent’s senior vice president, Innovation & Growth, said, “We are pleased to welcome Rao to Catalent. He brings with him extensive knowledge of life cycle management, brand and generic products, project management, new product and process development which will help him drive sustainable long-term growth for Catalent.”